Send to Friend | The Cornell Daily Sun

Send to Friend

From	To
Email: * First Name: Last Name: Send a copy to myself	Email: * First Name: Last Name:

CAPTCHA

This question is used to make sure you are a human visitor and to prevent spam submissions.

What code is in the image?: *

Copy the characters (respecting upper/lower case) from the image.

News from The Cornell Daily Sun

Message Text:

C.U. Researcher Critical of New HIV Treatment

October 11, 2007 - 12:00am
By Cara Sprunk

A Cornell medical researcher has been vindicated in his claim that a recently-released HIV vaccine would be unsuccessful after the drug was pulled last month from the market in South Africa.

Dr. Kendall A. Smith of Cornell Weill Medical College explained that the leading pharmaceutical company Merck’s vaccine went on to Stage II testing in South Africa because “the vaccine had no adverse affects in Stage I.”

Smith described that testing the effectiveness of this and all HIV vaccines is so difficult because there is no animal model for HIV. While doctors do test some vaccines on monkeys, because they have SIV (which affects simians as opposed to humans) it is difficult to find matching cures.